Metabolic syndrome prevalence is high in the U.S.
the ONA take:
Researchers have found a high prevalence of metabolic syndrome in the US population. Estimates are nearly 35% of all US adults and 50% of those 60 years and older in 2011-2012 have the condition.
Metabolic syndrome is a combination of health conditions, including obesity, high blood pressure, elevated blood sugar, and poor lipid profile that contribute to cardiovascular illness and death.
Researchers used National Health and Nutrition Examination Survey (NHANES) 2003-2012 data to evaluate trends in metabolic syndrome among adults age 20 years and older. Prevalence was higher in women compared with men.
When stratified by race/ethnicity, the highest prevalence was in Hispanics, followed by non-Hispanic whites and blacks. Overall prevalence increased from 32.9% in 2003-2004 to 34.7% in 2011-2012.
By age groups, prevalence of metabolic syndrome increased by age groups. Among people age 20 to 39 years, prevalence was 18.3%, and it increased to 46.7% among those 60 years or older. The researchers defined this as “a concerning observation given the aging US population.”
Greater awareness of the condition and its health consequences may be contributing to improved treatment of risk factors. Finally, recent NHANES data demonstrate that obesity rates are stabilizing, which may lead to stabilizing the prevalence of metabolic syndrome as well.
Researchers have found a high prevalence of metabolic syndrome in the US population.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Mammograms (Fact Sheet)
- Shifts in Cancer Burden for People With HIV Projected
- Tissue Biobank Procurement Consent Should Include Discussion of Confidentiality Risks
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|